2007
DOI: 10.1016/j.jcv.2007.06.012
|View full text |Cite
|
Sign up to set email alerts
|

Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes

Abstract: Background and PurposeA human gamma class herpesvirus within the rhadinovirus family known as Kaposi's sarcomaassociated herpesvirus (KSHV) or human herpesvirus 8 (HHV8) is now fully accepted as the etiological agent of both Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL), as well as of some cases of multicentric Castleman's didease (MCD). The rates of these diseases are greatly increased in certain AIDS subpopulations (epidemic form), less so in organ transplant patients (iatrogenic form), and they … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
17
0
5

Year Published

2009
2009
2017
2017

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(24 citation statements)
references
References 63 publications
2
17
0
5
Order By: Relevance
“…[25,27,45,46] Nevertheless, prevalence of detectable HHV-8 salivary shedding in the group without KS was 14.1% (as assessed herein by means of real-time PCR from ORF 73), which is close to the prevalence rates reported in previous studies, that is, ranging from 9.5 to 11%. [45,46] In the saliva samples from those non-KS individuals, our protocol using 3 sets of primers together (i.e., VR1, VR2, and K1) allowed us to genotype 32.1% of the samples, at even low viral load. In the PBMC samples from individuals with KS disease, our genotyping protocol reached 89.2% (33/37).…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…[25,27,45,46] Nevertheless, prevalence of detectable HHV-8 salivary shedding in the group without KS was 14.1% (as assessed herein by means of real-time PCR from ORF 73), which is close to the prevalence rates reported in previous studies, that is, ranging from 9.5 to 11%. [45,46] In the saliva samples from those non-KS individuals, our protocol using 3 sets of primers together (i.e., VR1, VR2, and K1) allowed us to genotype 32.1% of the samples, at even low viral load. In the PBMC samples from individuals with KS disease, our genotyping protocol reached 89.2% (33/37).…”
Section: Discussionsupporting
confidence: 83%
“…1B, gray area). In fact, most studies consistently demonstrate that co-infection by different HHV-8 genotypes is extremely rare, [26,46,5052] thus supporting that the currently detected recombinant forms do not originate from new events, but they represent previous circulating recombinant forms. [2,49] …”
Section: Discussionmentioning
confidence: 94%
“…Testing of serial samples collected from the patients revealed fluctuation in the genotype abundance although the sequence itself did not change, again confirming the stability of CMV genes. The authors appropriately noted that PCR amplification may result in artificial recombinants and cautioned about problems in interpretation of deep sequencing experiments (64,65). …”
Section: The Era Of Next Generation Sequencing (Ngs)mentioning
confidence: 99%
“…KSHV has different subtypes [Zong et al, 2007]. These subtypes have distinct geographic distributions, and appear to migrate with the human populations.…”
Section: Introductionmentioning
confidence: 99%